HIV drug resistance creeps higher: WHO

July 18, 2012 by Kerry Sheridan

Drug resistance to HIV medicines has been creeping higher in parts of Africa and Asia but is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday.

In low- and middle-income countries, drug resistance stood at 6.8 percent in 2010, the WHO said in its first-ever report on the matter released ahead of the International Conference in the US capital July 22-27.

"That is a level that we sort of expected. It is not dramatic but we clearly need to look very carefully on how this would evolve further," WHO AIDS chief Gottfried Hirnschall said in an interview.

Drug resistance can occur when the mutates naturally, when treatment is interrupted or patients take the medications incorrectly.

The 6.8 percent figure relates to the level of transmitted from one person to another, meaning those people were found to be resistant to the first-line of therapy they tried.

The other main type of resistance is one that develops in a patient who takes medications irregularly.

Since many more people in the are now receiving , experts have been closely monitoring to see whether a surge in drug resistance would accompany the increased coverage.

Some eight million people in low- and middle-income countries were being treated with antiretrovirals last year, up 20 percent from 2010 according to a separate report by UNAIDS released Wednesday.

High-income countries, many of which began widescale treatment for years earlier and used single or dual therapies that can also encourage resistance, face higher rates of resistance, from eight to 14 percent, said the study.

However, those rates have largely leveled off or decreased over time, Hirnschall noted.

"What we have also seen in these countries is it has stabilized or plateaued while we are still seeing a slight increase in low- and middle-income countries," he told AFP.

In 12 of the low- and middle-income countries included in the study, health care facilities lost contact with up to 38 percent of people who began treatment.

When people interrupt or stop their treatment altogether, "this not only means that they are themselves more likely to become sick, it also increases the likelihood that drug resistance will emerge and the resistant virus could be transmitted to others," the report said.

The WHO called for every clinic providing such treatment to monitor for early warning indicators that could signal encroaching resistance, including poor adherence to treatment, types of medicines used and supply breaks.

Also, any rise in the amount of virus detected in the patient's blood should serve as a signal that the treatment is failing, the WHO said.

For now, there is no need to change to current guidelines for administering antiretroviral drugs due to the slight rise in resistance, it added.

"Simpler regimens using fixed-dose combinations have made it much easier for people to adhere to antiretroviral treatment, limiting the spread of drug resistance in recent years. This is good news for public health," Hirnschall said.

Explore further: HIV drugs reach 8 million in needy countries

Related Stories

HIV drugs reach 8 million in needy countries

July 18, 2012
More than eight million people -- a record number in low- and middle-income countries -- are now taking antiretroviral drugs to treat HIV, according to data released Wednesday by UNAIDS.

Study finds early signs of malaria drug resistance in Africa

April 27, 2012
Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.